Skip to content

Clinical trials

Phase 3 Seizures trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20101
20122
20132
20191
20211
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Eisai Inc.2
Eisai Co., Ltd.1
Epygenix1
Population Health Research Institute1
SK Life Science, Inc.1
UCB Japan Co. Ltd.1
UCB Pharma SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures14
Epilepsy11
Lennox Gastaut Syndrome3
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Blood Loss, Surgical1
Epilepsies, Partial1
Hemorrhage1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.